Adiposs key facts
as of Oct 2026- Developer of medical imaging products and technologies designed for the early detection of cachexia, a devastating body-wasting syndrome.
- Adiposs is valued at approximately $48.8M as of Oct 2026 (last reported valuation).
- It has raised $7.3M; the latest was Later Stage VC ($4.9M) in Jul 2025.
- Notable investors include MassChallenge, Venture Kick, Kickfund, Kingbridge, CR Ventures (Acquired in 2022) — 11 tracked in total.
- Status: Privately Held (backing).
Adiposs's last reported valuation, Dec 2021. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Adiposs: the Monday email on marks, rounds and moves
Adiposs funding rounds
No funding rounds for Adiposs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Adiposs
11+Adiposs valuation
Adiposs's last reported valuation was $48.8 million in Dec 2021. No priced round, secondary trade or fund mark has surfaced since.
Adiposs investors
11 investors are on record for Adiposs, including MassChallenge, Venture Kick, Kickfund and Kingbridge.
About Adiposs
Developer of medical imaging products and technologies designed for the early detection of cachexia, a devastating body-wasting syndrome. The company's CT contrast product can detect body wasting early, before weight loss, a year earlier, enabling hospitals and healthcare providers to detect cancer early, improve patients' quality of life, and give them a better chance to survive cancer and other chronic diseases.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2004
- Employees
- 6
- Website
- adiposs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.